Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.
A study looking for a new way of detecting lung cancer in people who are at high risk (MEDLUNG)
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This study is trying to find a new way of screening for lung cancer in people who are having tests for lung cancer.
More about this trial
Doctors usually diagnose lung cancer after somebody develops symptoms or has an abnormal chest X-ray. But by that time, it can be quite advanced. Researchers are looking for ways to screen people who are at high risk of getting lung cancer. If it can be found earlier, treatment is more likely to be successful.
A biomarker is a substance in the body that doctors can measure, which helps them to see if a disease is developing. In this trial, researchers are trying to find biomarkers that show lung cancer is developing before there are any symptoms. They will look at samples of sputum to try and find changes in the cells.
The aim of this study is to find a
Please note - taking part in this study will not affect any treatment you have if you are diagnosed with lung cancer. The results may lead to the development of a new screening tool and help people who have lung cancer in the future.
Who can enter
The researchers will take 1 or 2 samples of your sputum.
If you are diagnosed with lung cancer, you will have the standard treatment.
Whether or not you are diagnosed with lung cancer, you will have a follow up appointment once a year for 5 years as part of this study. The researchers may ask you to give more sputum samples at these appointments.
There are no side effects from taking part in this study.
How to join a clinical trial
Dr Keir Lewis
Hywel Dda University Health Board
NIHR Clinical Research Network: Cancer
University of Wales Swansea
Welsh Assembly Government